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Abstract 
Background and aims: Sex differences in measures of cardiovascular health in adults are well 
documented. However, the sex-specific aetiology of cardiovascular health across childhood and 
adolescence is poorly understood.  
Material and methods: We examined sex differences in trajectories of 11 measures of cardiovascular 
health from birth to 18 years, in a contemporary birth cohort study in England (N participants per 
outcomes: 662-13,985, N repeated measures per outcome: 1,831-112,768). Outcomes were 
measured over varying time spans from birth or mid-childhood to age 18 and with different numbers 
of repeated measures per outcome. Analyses were performed using fractional polynomial and linear 
spline multilevel models.  
Results: Females had higher mean BMI, height-adjusted fat mass, pulse rate, insulin, triglycerides, and 
non-high-density lipoprotein cholesterol (HDL-c) and lower mean height-adjusted lean mass from 
birth or from mid-childhood to age 18. For example, mean non-HDL-c was 0.07 mmol/l (95% 
Confidence Interval (CI), 0.04, 0.10) higher in females compared with males at birth. By age 18, this 
difference persisted and widened to 0.19 mmol/l (95% CI, 0.16, 0.23) higher non-HDL-c in females 
compared with males. Females had lower levels of glucose from mid-childhood and developed lower 
systolic blood pressure and higher HDL-c from mid-adolescence onward. For example, females had 
0.08 mmol/l (95% CI, 0.05, 0.10) lower mean glucose compared with males at age 7 which widened to 
a difference of 0.22 mmol/l (95% CI, 0.25, 0.19) at age 18.  
Conclusions: Sex differences in measures of cardiovascular health are apparent from birth or mid-
childhood and change during early life. These differences may have implications for sex-specific 
disease risk in future adult populations.  
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Introduction 
Cardiovascular disease (CVD) is a leading cause of death worldwide and its prevalence continues to 
increase globally. (1, 2) Women and men do not experience cardiometabolic diseases (CVD and type 
2 diabetes mellitus (T2DM)) equally. For instance, at age 40, the remaining lifetime risk of CVD is one 
in two for women and two in three for men. (3, 4) Women are also less insulin resistant than men 
and develop T2DM at higher levels of adiposity. (5) However, amongst people with T2DM, coronary 
heart disease (CHD) and stroke risk are up to 50% higher in women compared with men. (6, 7) 
Despite these well-established sex differences, the sex-specific aetiology of cardiovascular risk 
remains poorly understood. Recent guidelines and scientific statements emphasise the importance 
of studying sex differences in cardiovascular risk in adults. (8-11) Given that cardiovascular risk 
originates in early life (12-14) and tracks through the life course (15-17), there is also a need to study 
potential sex differences during childhood and adolescence. Longitudinal studies of sex differences 
in measures of cardiovascular health during childhood and adolescence can help to establish when 
sex differences emerge and how sex differences change over time, contributing to understanding 
the mechanisms underlying sex differences in cardiovascular disease risk across the life course. 
 
To date, sex differences in selected measures of cardiovascular health have been examined during 
childhood and adolescence in a small number of US studies, including change in blood pressure (18) 
and lipids (19) in 678 children aged eight to 18 years in the Project Heartbeat! and change in glucose 
and  insulin from 5 to 17 years (20) and lipids from 5 to 26 years (21) in the Bogalusa Heart Study.  A 
more recent study in 507 children in Minneapolis examined change over time in 10 conventional 
measures of cardiovascular health measured up to 3 times from 11 to 19 years. (22) Recent analyses, 
combining data from several cohorts across the life course have also examined sex differences in 
trajectories of blood pressure over time. (23) However, large contemporary studies with repeated 
measures of all key measures of cardiovascular health together from early life through adolescence 
are lacking. Contemporary studies of measures of cardiovascular health in early life are of particular 
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importance given the high prevalence of overweight and obesity during childhood and adolescence 
compared with previous generations. (24) Studies of successive generations are also important given 
the significant changes in lifestyle that have occurred over time, (25) in both sexes but particularly 
among women, which will likely impact future sex-specific disease burden in the population. 
We examine sex-specific trajectories of a range of measures of cardiovascular health measured at 
multiple time points across childhood and adolescence in a prospective birth cohort study of 
participants born in 1991-2 in the South West of England. The risk factors we consider are body mass 
index (BMI) measured repeatedly from age 1 to 18 years, fat mass and lean mass measured from 9 
to 18 years, systolic blood pressure (SBP), diastolic blood pressure (DBP), pulse rate and glucose 
measured from 7 to 18 years, and insulin, triglycerides, high density lipoprotein cholesterol (HDL-c), 
and non-HDL-c measured from birth to 18 years.  
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Subjects and Methods 
Study participants 
The Avon Longitudinal Study of Parents and Children (ALSPAC) is a prospective birth cohort study in 
Southwest England. (26, 27) Pregnant women resident in one of the three Bristol-based health 
districts with an expected delivery date between April 1, 1991 and December 31, 1992 were invited 
to participate. The study has been described elsewhere in detail. (26, 27) ALSPAC initially enrolled a 
cohort of 14,451 pregnancies, from which 13,867 live births occurred in 13,761 women. Follow-up 
has included parent and child completed questionnaires, links to routine data and clinic attendance. 
Research clinics were held when the participants were approximately 7, 9, 10, 11, 13, 15, and 18 
years old. Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee 
and the Local Research Ethics Committees. The study website contains details of all the data that is 
available through a fully searchable data dictionary 
http://www.bristol.ac.uk/alspac/researchers/access/. (28)  
Study outcomes 
Anthropometry 
Height and weight were modelled previously and are not included here.(29-31) BMI (weight (kg) 
divided by height squared (m2)) was calculated from 1 to 18 years using data from several sources 
including research clinics, routine child health clinics, health visitor records and questionnaires. 
Whole body less head, and central fat and lean mass were derived from whole body dual energy X-
ray absorptiometry (DXA) scans assessed 5 times at ages 9, 11, 13, 15, and 18 using a Lunar prodigy 
narrow fan beam densitometer.  
SBP, DBP and pulse rate 
At each clinic (ages 7, 9, 10, 11, 13, 15 and 18), SBP, DBP and pulse rate were measured at least 
twice each with the child sitting and at rest with the arm supported, using a validated device and a 
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cuff size appropriate for the child’s upper arm circumference. The mean of the two final measures is 
used here.  
Blood based biomarkers 
Insulin was measured from cord blood at birth. Non-fasting glucose was measured at age 7 as part of 
metabolic trait profiling, using Nuclear Magnetic Resonance (NMR) spectroscopy. In a random 10% 
of the cohort at age 9 years, fasting glucose and insulin were also available; were taken as part of a 
continuation of an earlier sub-study called “Child in Focus” which included approximately 10% of the 
overall cohort. Fasting glucose and insulin were available from research clinics held when 
participants were 15 and 18 years old.  Triglycerides, HDL-c and total cholesterol were measured in 
cord blood at birth and from venous blood subsequently. Samples were non-fasted at 7 and 9; 
fasting measures were available from clinics at 15 and 18 years. Non-HDL-c was calculated by 
subtracting HDL-c from total cholesterol at each measurement occasion. Trajectories of glucose, 
insulin, triglycerides, HDL-c, non-HDL are thus a combination of measures from cord blood, fasting 
bloods and non-fasting bloods, with most measures obtained through standard clinical chemistry 
assays, but one measure (glucose at age 7) by NMR spectroscopy. 
Further details of measurement of study outcomes are available in ref (32). 
Statistical analysis 
We used multilevel models to examine the sex-specific patterns of change in each risk factor. (33, 
34) Multilevel models estimate mean trajectories of the outcome while accounting for the non-
independence (i.e. clustering) of repeated measurements within individuals, change in scale and 
variance of measures over time, and differences in the number and timing of measurements 
between individuals (using all available data from all eligible participants under a Missing at Random 
(MAR) assumption). (29, 35) All trajectories except BMI (fat mass, lean mass, SBP, DBP, pulse rate, 
glucose, insulin, triglycerides, HDL-c, non-HDL-c) were estimated using linear spline multilevel 
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models (two levels: measurement occasion and individual). Trajectories of BMI were modelled using 
fractional polynomials (36) (two levels: measurement occasion and individual), since change in BMI 
during childhood follows a complex pattern that cannot be parsimoniously modelled using linear 
splines. Linear splines allow knot points to be fit at different ages to derive periods in which change 
is approximately linear. Fractional polynomials involve raising age to many combinations of powers, 
resulting in a wide range of possible curves and offering more flexibility than standard polynomial 
approaches.  
Trajectories were modelled separately for females and males to allow for different random effect 
variances between the sexes, i.e. allowing the between subject variability in outcomes to be 
different for males and females. Sex differences in the mean intercept and slopes of risk factors were 
examined by calculating the mean difference between the sexes for each risk factor and using the 
pooled standard error to calculate 95% confidence intervals for the difference. Values of 
cardiovascular risk factors that had a skewed distribution (BMI, fat mass, insulin and triglyceride) 
were (natural) log transformed prior to analysis. Differences between the sexes and confidence 
intervals were calculated on the log-scale. These values were then back-transformed and are 
interpreted as the ratio of geometric means. Graphs displayed for these outcomes are in original 
units and values were derived by back transforming from the log scale. Fat mass and lean mass were 
adjusted for height using the time- and sex-varying power of height that best resulted in a height-
invariant measure (see Table 2 in ref (32) for further details). All trajectories were modelled in 
MLwiN version 2.36 (37), called from Stata version 14 (38) using the runmlwin command. (39) We 
performed a number of sensitivity analyses to examine the robustness of our findings. Further 
details of model selection (Table 3-13 of ref (32)) and sensitivity analyses performed are provided in 
Supplemental Material.  
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Results 
Sample sizes for different outcomes ranged from 662 participants (1,831 repeated measures) for 
insulin up to 13,985 participants (112,768 repeated measures) for BMI (Table 1). Mothers of 
participants included in the analysis of insulin tended to be more advantaged than mothers of 
participants excluded due to missing data but there were no differences in the distribution of sex 
between included and excluded participants (Table 14 in ref (32)). 
Anthropometry  
Mean BMI was similar in females and males at 1 year but by age 3 BMI was lower in females 
compared with males (Figure 1) and (Table 15 in ref (32)). From age 7 years onward, mean BMI was 
higher in females. At age 18, mean BMI was 2.4% (95% Confidence Interval (CI), 1.6, 3.1%) higher in 
females compared with males.  
Height-adjusted fat mass was higher in females compared with males at age 9. This difference 
widened over time, particularly from age 13 onward due to an increase in the average height-
adjusted fat mass in females. At age 18, mean height-adjusted fat mass was 77.8% (95% CI, 73.0, 
82.8%) higher in females. In comparison, height-adjusted lean mass was lower in females at age 9 
years. The trajectories converged at age 13 but widened again thereafter due to a slower rate of 
increase in height-adjusted lean mass in females. At age 18, mean height-adjusted lean mass was 
18.4 kg (95% CI, 18.1, 18.7 kg) lower in females. 
SBP, DBP and pulse rate 
At age 7 years, males and females had similar SBP (Figure 2) and (Table 16 in ref (32)). SBP increased 
at a faster rate in females compared with males from 7 to 12 years but at a slower rate from 12 to 18 
years resulting in a lower mean SBP in females from approximately age 13 onwards. At age 18, mean 
SBP was 10mmHg (95% CI, 10, 11 mmHg) lower in females. At age 7 years, DBP was higher in 
females. DBP increased at a similar rate in females and males up to age 12 whereas females 
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increased at a slower rate from 12 to 16. From 16 to 18, DBP decreased in both sexes but at a faster 
rate in males leading to a 1.7 mmHg (95% CI, 1.3, 2.0. mmHg) higher DBP in females at age 18. At age 
7 years, females had a higher mean pulse rate compared with males. In both sexes, pulse rate 
decreased with age and rates of change were similar between the sexes.  At age 18, mean pulse rate 
was 4.7 beats per minute (bpm) (95% CI, 4.1, 5.2 bpm) higher in females. 
Glucose and insulin 
At age 7 years, females had lower glucose levels compared with males (Figure 3) and (Table 17 in ref 
(32)). Glucose increased similarly in both sexes from 7 to 15 years and decreased from 15 to 18 
years, with a faster rate of decrease in females. At age 18, mean glucose was 0.2 mmol/l (95% CI, 
0.2, 0.3 mmol/l) lower in females.  
At birth, females and males had similar insulin levels. Insulin increased in both sexes at a broadly 
similar rate until age 15 and decreased thereafter at a similar rate in both sexes. At age 18, mean 
insulin was 23.8% (95% CI, 10.8, 36.4%) higher in females. 
Lipids 
Females had similar triglycerides at birth but higher HDL-c and non-HDL-c compared with males 
(Figure 4) and (Table 18 in ref (32)). From birth to 9 years, triglycerides and non-HDL-c increased in 
both sexes but at a faster rate in females. From birth to 7 years, HDL-c also increased in both sexes 
but at a slower rate in females.  
From 9 to 18 years, rates of change in triglycerides and non-HDL-c did not differ substantially 
between females and males. In contrast, HDL-c decreased at a faster rate in males from 7 to 18. At 
age 18 years, females had 3.8% (95% CI, 1.6, 6.1%) higher triglycerides, 0.17 mmol/l (95% CI, 0.15, 
0.18 mmol/l) higher HDL-c and 0.19 mmol/l (95% CI, 0.16, 0.23 mmol/l) higher non-HDL-c compared 
with males.  
Sensitivity analyses 
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Our results examining sex differences in the observed data at the first occasion of measurement and 
last occasion of measurement (age 18) for each risk factor were similar to those predicted from the 
multilevel model at those ages and age 18 (Table 19 in ref (32)). Results were not substantially 
different when including only individuals with at least one measure before and one measure after 11 
years (Figures 1-4 in ref (32)). Results for BMI were not altered when the analysis was restricted to 
participants with 6 or more repeated measures (Figures 5 in ref (32)). Results were not altered when 
the observations of participants who did not fast in the four hours before the 15-and 18-year clinics 
were excluded from the models at those time points only (Figures 6&7 in ref (32)). Sex difference in 
glucose at ages 15 and 18 years, were similar whether standard clinical chemistry or NMR 
spectroscopy had been used to measure glucose (Table 1 in ref (32)). This suggests that that the 
different glucose measure used at age 7 (NMR spectroscopy) and included in the trajectories 
compared to the measures used at later time points (from standard clinical chemistry) is unlikely to 
have influenced our findings. Our results for any measures of cardiovascular health were not altered 
when the observations of participants taking antihypertensive medications at the 18-year clinic (n=6) 
were excluded from analysis (data not shown).  
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Discussion 
In this paper, we examined longitudinal changes in 11 measures of cardiovascular health from early 
childhood through to 18 years in a large contemporary prospective birth cohort study. We found 
that sex differences in measures of cardiovascular health were apparent in early life and followed 
different patterns from childhood to early adulthood. Consistent with adult sex differences in 
contemporary populations  (40, 41), females had higher height-adjusted fat mass, pulse rate and 
lower height-adjusted lean mass and glucose from mid-childhood through adolescence and up to 
age 18. Also consistent with adult sex differences (42-44), males developed higher SBP and lower 
HDL-c during adolescence. In contrast to  adult sex differences (42, 45), we found that females had 
higher levels of insulin, triglycerides and non-HDL-c from birth or mid-childhood through 
adolescence and developed higher DBP by the end of adolescence. These findings have implications 
for understanding the sex-specific aetiology of cardiovascular risk across the life course and for sex 
differences in measures of cardiovascular health in future adults as contemporary child and 
adolescent populations mature.  
Implications 
Sex differences in absolute levels of many risk factors (45, 46), rather than sex differences in their 
relative association with CVD risk (with some exceptions (47)) are thought to be the greatest 
contributor to sex differences in cardiovascular disease risk in adults. Thus, understanding the 
mechanisms underlying sex differences in measures of cardiovascular health and differentiating 
naturally arising sex differences (due to genetic and hormones) compared with those which are 
modifiable may provide sex-specific prevention opportunities. Several mechanisms have been 
proposed to underlie sex differences in measures of cardiovascular health but these remain poorly 
understood. (48)  Our findings demonstrate that sex differences in measures of cardiovascular 
health in early life are each potentially driven by unique mechanisms due to substantial variation, 
between risk factors, in how sex differences emerge and change from birth to 18 years. For example, 
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sex differences in height-adjusted fat mass and lean mass were evident at age 9 and widened during 
adolescence (with girls having higher height-adjusted fat mass and lower height-adjusted lean mass). 
This suggests that sex differences in these are associated with mechanisms that pre-date 
adolescence but are further widened potentially due to hormonal changes associated with puberty. 
These hormonal changes, alongside changes in growth velocity and health behaviours, may also be 
associated with the emergence of the sex differences in SBP and HDL-c during adolescence. Our 
findings showed a rise in SBP and decrease in HDL-c in males in adolescence leading to a 10 mmHg 
higher SBP and 0.17 mmol/l lower HDL-c compared with females by age 18. However, this pattern of 
widening sex differences during adolescence was not common to all measures of cardiovascular 
health examined here. Sex differences that were present at birth and persisted throughout 
childhood and adolescence (non-HDL-c) may implicate genetics as an underlying mechanism, as the 
sex difference pre-dates exposure to the post-natal environment and gendered lifestyle behaviours. 
Further studies of the specific mediators of the sex differences identified here, such as pubertal 
timing, secondary sex characteristics, growth and lifestyle behaviours (smoking and physical activity) 
will be an important next step in understanding the sex-specific aetiology of cardiovascular risk. 
However, we acknowledge that we only have measures at birth for a small number of blood-based 
risk factors (insulin, triglycerides, HDL-c and non-HDL-c), with the next measure for these being 
several years later (between 7 to 9 years), preventing the modelling of change over time in infancy 
and early childhood with greater resolution. 
We found several sex differences in measures of cardiovascular health in childhood and adolescence 
which were not comparable to sex differences in previous childhood generations or contemporary 
adult populations that warrant further follow-up.  For example, females had higher DBP, 
triglycerides, and non-HDL-c at the end of adolescence in contrast to lower levels of these among 
females in other childhood cohorts (18, 21, 22, 49, 50)  and contemporary adults. (42-44) It is 
possible that sex differences in these will change during early adulthood, and eventually lead to 
lower levels in females. However, it is also possible that the different patterns of these in this 
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population compared with previous generations are due to a cohort effect because of increasing 
overweight and obesity in contemporary child populations. (24) Studies with repeated measures of 
cardiovascular risk factors across adolescence and into adult life are needed to examine how these 
sex differences track into adulthood and whether the pattern of sex differences in contemporary 
child and adolescent populations differs from sex differences in previous generations.  
Comparison with existing studies 
Few studies have examined sex differences in trajectories of measures of cardiovascular health 
through childhood and adolescence in contemporary populations. However, our findings are 
comparable with some earlier prospective studies. The Minneapolis Cohort Study (N=507) showed 
that whilst fat mass was higher in females from 11 to 19 years, similar rates of change in glucose, 
insulin, HDL-c, triglycerides, and non-HDL-c were observed for both sexes during adolescence such 
that sex differences remained stable during this period. (22) Project Heartbeat! (N=678) reported 
that sex differences in SBP began to emerge after age 11 years, with male SBP increasing at a faster 
rate, resulting in a lower SBP in females compared with males by age 18, consistent with our 
findings. (18) Our data support findings from the Bogalusa Heart Study (N=3,313), which showed 
that females had higher insulin and lower glucose than males from 5 to 17 years. (20) Project 
Heartbeat! and the Minneapolis Cohort Study found the same crossover from higher HDL-c in males 
to higher HDL-c in females in adolescence, as we have demonstrated here. However, both studies 
showed higher triglycerides and non-HDL-c in males compared with females by the end of 
adolescence, in contrast to our findings of higher levels of these in females at age 18.   
Strengths and Limitations 
There are several strengths to our study, including its prospective design, availability of repeated 
measures, the ability to examine a range of measures of cardiovascular health, and the use of multi-
level models which take account of clustering of repeated measures within individuals and the 
correlation between measures over time. We have also adjusted fat and lean mass using age-and 
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sex-specific powers of height; this approach is likely to result in a more accurate estimation of sex 
differences across childhood and adolescence. Limitations include combining non-fasting and fasting 
bloods for risk factors, the availability of measures from birth for only 4 out of the 11 risk factors, 
and the inclusion of glucose from NMR spectroscopy at age 7. We acknowledge that assays in cord-
blood may not be directly comparable to those measured in serum or plasma later in life. 
Furthermore, with a period of 9 or more years after the cord blood measures before the next 
measure of insulin, triglycerides HDL-c and non-HDL-c, there is a strong assumption that these 
measures of cardiovascular health change in a linear way between birth and age 9. However, while 
different sources of blood-based measures may affect the estimated mean shape of the trajectories 
over time, different measurements and assay methods are unlikely to impact the direction and 
magnitude of the estimated sex difference. Supporting this, the sex differences in glucose measured 
using conventional clinical chemistry assays and NMR spectroscopy at age 15 and 18 were highly 
comparable.  We have not explored the potential role of medications such as antihyperlipidemic 
drugs in this study; however, their prevalence is likely to be low in this population and the impact of 
medication use on our overall findings and the sex differences reported is likely to be minimal, as 
demonstrated when observations of individuals taking antihypertensive medications were excluded. 
A further limitation includes the use of BMI as a measure of adiposity which has several limitations in 
children despite its widespread use including, being unable to distinguish fat and lean mass, masking 
sex differences in these and its varying correlation with adiposity with age (as assessed directly by 
DXA scans) throughout childhood. However, we have included direct measures of height-adjusted 
fat mass and lean mass from DXA scans which provide more accurate insight into sex-and age-
related change in body composition over time than BMI. The number of people with measurements 
of each measures of cardiovascular health varied, meaning that our analysis samples differed 
between measurements and are not directly comparable. Loss to follow-up is also a limitation; 
however, we have shown that sex is not associated with exclusion from our analysis and we have 
also aimed to minimise potential bias by including all participants with at least a single measure of a 
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risk factor. In addition, we have shown that participants included in our analysis were more 
advantaged than those excluded due to missing data and loss-to-follow-up. Thus, the generalisability 
of our findings to the wider population may be limited. Furthermore, our findings are not 
generalisable to non-White populations as 98% of ALSPAC participants are Caucasians. 
Conclusion 
Sex differences in measures of cardiovascular health are apparent from birth or mid-childhood and 
change across the early life course, suggesting that early life factors may play a role in sex 
differences in cardiovascular disease. Further studies of the specific mechanisms underlying these 
sex differences and how sex differences in contemporary child and adolescenct populations track 
into adulthood are required  
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Table 1 Number of Participants with Cardiovascular Measures at Each Time Point Included in the 
Analysis from Birth to 18 years 
 
 Birth Age 
7 
Age 
9 
Age 
10 
Age 11 Age 
12 
Age 
13 
Age 
15 
Age 
18 
Total 
measures 
Median 
measures 
(IQR) 
BMI a  x x x x x x x x 112,768 12 (9-15) 
Fat/lean mass   7,241  6,963  6,009 5,126 4,804 30,143 4 (3-5) 
SBP/DBP/pulse rate  8,057 7,586 7,152 6,996 6,624  5,277 4,629 45,961 5 (6-7) 
Glucose  5,480 842     3,464 3,266 13,052 2 (1-3) 
Insulin b 262  550     521 498 1,831 3 (3-3) 
Lipids c 4,770 5,394 5,048     3,460 3,254 21,926 3 (2-4) 
            
DBP, diastolic blood pressure; HDL-c, high density lipoprotein cholesterol; IQR, interquartile range; 
non-HDL-c, non-high-density lipoprotein cholesterol; SBP, systolic blood pressure. 
a Measures available at each of these approximate ages and at several ages in between but exact 
timing and number of BMI measures not shown as a total of 112,768 BMI measures were available 
from questionnaires, routine child health records and research clinics at different mean ages from 1 
to 18 years.  
b Additional measures available at these ages but the model was restricted to participants with at 
least one measure before and after age 11 years to allow model convergence. 
c Triglycerides, HDL-c and non-HDL-c. 
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N=13,985     N=8,802     N=8,818 
Figure 1 Mean predicted sex-specific trajectories of anthropometry. 
Mean trajectories of A) BMI from 1 to 18 years B) height-adjusted fat mass and C) height-adjusted lean mass both from 9 to 18 years in the ALSPAC cohort, 
predicted from multilevel models. Shaded areas represent 95% confidence intervals. Note the different age range on the X axis for each outcome. Fat mass 
and lean mass were measured at 9, 11, 13, 15 and 18 years are adjusted for different age-and sex-specific powers of height. BMI was measured a median of 
32 times from 1-18 years. Further details are included in ref (32). 
 
24 
 
 
 
 
N=9,922     N=9,922   N=9,922 
Figure 2 Mean predicted sex-specific trajectories of blood pressure and pulse rate 
Mean trajectories of A) SBP, B) DBP and C) pulse rate from 7-18 years in the ALSPAC cohort, predicted from multilevel models. Shaded areas represent 95% 
confidence intervals. Note the different age range on the X axis for each outcome. SBP, systolic blood pressure; DBP, diastolic blood pressure. SBP, DBP and 
pulse rate were measured at 7, 9, 10, 11, 13, 15 and 18 years. Further details are included in ref (32). 
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N=7,255     N=662 
Figure 3 Mean predicted sex-specific trajectories of glucose and insulin. 
Mean trajectories of A) glucose from 7 to 18 years and B) insulin from birth to 18 years in the ALSPAC cohort, predicted from multilevel models. Shaded 
areas represent 95% confidence intervals. Note the different age range on the X axis for each outcome. Glucose was measured at 7, 9, 15 and 18 years. 
Insulin was measured at birth, 9, 15 and 18 years. Further details are included in ref (32). 
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N=10,128    N=10,115      N=10,098 
Figure 4 Mean predicted sex-specific trajectories of lipids from birth to 18 years 
Mean trajectories of A) triglyceride, B) HDL-c and C) Non-HDL-c from birth to 18 years in the ALSPAC cohort, predicted from multilevel models. Shaded areas 
represent 95% confidence intervals. HDL-c, high density lipoprotein cholesterol. All three lipids were measured at birth, 7, 9 15 and 18 years. Further details 
are included in ref (32). 
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